|Grade Standard||Medicine Grade|
|Packaging Type||Blister pack|
|Type Of Medicines||Allopathic|
We are the Leading exporters of Trima (Moclobemide) is indicated for social anxiety and depression and it works by affecting chemicals in the brain called monoamine neurotransmitters. This medicine is classified as a reversible monoamine oxidase inhibitor (RIMA), and it is able to both reversibly and selectively inhibit the MAO-A isozyme. When administered, it stops monoamine oxidase A from breaking down the chemicals in the brain that can contribute to a positive mood (including dopamine and serotonin). In this way, it is able to exhibit its antidepressant effects. Prominent medical researchers have conducted studies on its effects if used for fibromyalgia. Trima (Moclobemide) comes in tablet form and there are 150mg and 300mg strength varieties available. Your physician will conduct a thorough and full assessment of your disorder and calculate a dosage regiment designed to suit your individual needs. Adults treating depression may be told by their physician to take 300mg per day (as 2 separate doses), and those suffering from social phobia might be instructed (by the physician providing treatment) to take 150mg (twice per day) for a 3 day period, which may then be increased to 300mg twice per day if deemed necessary.